Iovance Biotherapeutics (IOVA)
(Delayed Data from NSDQ)
$11.72 USD
-0.08 (-0.68%)
Updated Apr 18, 2024 04:00 PM ET
After-Market: $11.71 -0.01 (-0.09%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/14/24 |
---|---|
Current Quarter | -0.45 |
EPS Last Quarter | -0.45 |
Last EPS Surprise | -2.27% |
ABR | 1.14 |
Earnings ESP
|
-3.79% |
---|---|
Current Year | -1.41 |
Next Year | -0.95 |
EPS (TTM) | -1.88 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.90M | 25.75M | 160.45M | 328.30M |
# of Estimates | 6 | 6 | 7 | 5 |
High Estimate | 6.00M | 41.12M | 274.12M | 514.00M |
Low Estimate | 0.48M | 5.20M | 33.20M | 130.50M |
Year ago Sales | 0.00M | 0.24M | 1.19M | 160.45M |
Year over Year Growth Est. | NA | 10,630.42% | 13,394.11% | 104.62% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.45 | -0.39 | -1.41 | -0.95 |
# of Estimates | 7 | 6 | 8 | 7 |
Most Recent Consensus | -0.47 | -0.43 | -1.57 | -1.23 |
High Estimate | -0.40 | -0.31 | -0.90 | -0.03 |
Low Estimate | -0.50 | -0.45 | -1.80 | -1.58 |
Year ago EPS | -0.50 | -0.47 | -1.89 | -1.41 |
Year over Year Growth Est. | 10.00% | 17.02% | 25.40% | 32.07% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 0 |
Up Last 60 Days | 2 | 1 | 4 | 2 |
Down Last 7 Days | 0 | 0 | 1 | 0 |
Down Last 30 Days | 1 | 1 | 0 | 1 |
Down Last 60 Days | 2 | 2 | 4 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.45 | -0.39 | -1.41 | -0.95 |
7 Days Ago | -0.45 | -0.39 | -1.40 | -0.95 |
30 Days Ago | -0.45 | -0.39 | -1.41 | -0.94 |
60 Days Ago | -0.42 | -0.37 | -1.42 | -0.30 |
90 Days Ago | -0.40 | -0.36 | -1.40 | -0.30 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.47 | -0.43 | -1.57 | -1.23 |
Zacks Consensus Estimate | -0.45 | -0.39 | -1.41 | -0.95 |
Earnings ESP | -3.79% | -9.79% | -11.74% | -29.09% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.45 | -0.46 | -0.47 | -0.50 | NA |
Estimate | -0.44 | -0.46 | -0.81 | -0.84 | NA |
Difference | -0.01 | 0.00 | 0.34 | 0.34 | 0.17 |
Surprise | -2.27% | 0.00% | 41.98% | 40.48% | 20.05% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more